Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?. (Record no. 57)

000 -LEADER
fixed length control field 04362nam a22006377a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130224s20132013 xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number 23850522
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0894-7317
190 ## -
-- Alyeshmerni D
190 ## -
-- Pirmohamed A
190 ## -
-- Barac A
190 ## -
-- Smirniotopoulos J
190 ## -
-- Xue E
190 ## -
-- Goldstein S
190 ## -
-- Mazel J
190 ## -
-- Lindsay J
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Barac, Ana
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Xue, Eric
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Goldstein, Steven A
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Mazel, Jay A
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Lindsay, Joseph
245 ## - TITLE STATEMENT
Title Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?.
251 ## -
-- Journal of the American Society of Echocardiography. 26(9):1099-105, 2013 Sep.
252 ## -
-- J Am Soc Echocardiogr. 26(9):1099-105, 2013 Sep.
253 ## -
-- Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
501 ## - WITH NOTE
With note Available online from MWHC library: 1995 - present
520 ## - SUMMARY, ETC.
Summary, etc. BACKGROUND: Transesophageal echocardiography (TEE) is commonly used before atrial flutter (AFl) ablation to detect atrial thrombus (AT) and thereby identify a heightened risk for systemic embolism both in patients with their initial episodes of AFl and in those with prior episodes whose anticoagulation has been inadequate. This treatment strategy has been extrapolated from guidelines for atrial fibrillation. In fact, limited data exist regarding the prevalence or clinical associations of AT and spontaneous echocardiographic contrast (SEC) in patients with AFl. Both AT and SEC are believed to represent risk factors for systemic embolization. This study was designed to provide further insight into the prevalence of these and their associated clinical findings.
520 ## - SUMMARY, ETC.
Summary, etc. METHODS: The results of transesophageal echocardiographic examinations in 347 consecutive patients with AFl in whom radiofrequency ablation procedures were planned were reviewed. In each case, specific care was taken to identify AT and SEC. The presence of either AT or more than mild SEC was considered to reflect a thrombogenic milieu (TM). Clinical and echocardiographic data were analyzed to determine the frequency and relevant clinical associations of these two markers of increased thromboembolic risk. In addition to determining the prevalence of AT and TM, the study sought to identify predictors of their presence short of TEE that might allow that procedure to be avoided.
520 ## - SUMMARY, ETC.
Summary, etc. RESULTS: AT were found in 19 of the 347 patients (5.4%). TM was present in 39 patients (11.2%). SEC was associated with reduced left atrial appendage emptying velocity (P < .001). History of myocardial infarction (P = .02) was associated with AT. Reduced left ventricular ejection fraction (P = .01), reduced left atrial appendage emptying velocity (P < .001), diabetes mellitus (P = .02), congestive heart failure (P = .04), and chronic renal insufficiency (P = .05) were associated with a TM.
520 ## - SUMMARY, ETC.
Summary, etc. CONCLUSIONS: Allowing for multiple comparisons, the significant markers of the risk for systemic embolization could be obtained only from TEE. Although there are several interesting clinical and echocardiographic associations with AT and a TM, none were strong enough to obviate the need for TEE. Published by Mosby, Inc.
546 ## - LANGUAGE NOTE
Language note English
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Geographic name MedStar Heart & Vascular Institute
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticoagulants/tu [Therapeutic Use]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Atrial Flutter/su [Surgery]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Atrial Flutter/us [Ultrasonography]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Catheter Ablation
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Echocardiography, Transesophageal/mt [Methods]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Guideline Adherence
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heart Atria/us [Ultrasonography]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Mass Screening
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patient Safety
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Preoperative Care
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sensitivity and Specificity
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombosis/us [Ultrasonography]
657 ## - INDEX TERM--FUNCTION
Function Journal Article
857 ## -
-- http://dx.doi.org/10.1016/j.echo.2013.05.017
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0894731713004057?returnurl=null&referrer=null
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Permanent Location Current Location Date acquired Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 2014-02-24 23850522 2014-02-24 2014-02-24 Journal Article

Powered by Koha